Physician profile
Scott D Ross
NPI 1164413563
$12,140.44
in general payments reported to CMS, 2019-2025
25 companies · $3,072 in 2025
The $3,072 reported for 2025 was more than what 75% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,737 · 2020: $1,717 · 2021: $523 · 2022: $1,014 · 2023: $1,106 · 2024: $1,971 · 2025: $3,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,996 · Travel and Lodging: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,996.26 |
| Travel and Lodging | $153.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $6,195.40 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Atricure, INC. | $2,123.91 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System |
| Abbott Laboratories | $2,026.95 | 2019-2022 | |
| Cms Imaging, INC. | $390.85 | 2022 | |
| Mid-Atlantic Surgical Systems, LLC | $297.71 | 2025 | |
| Livanova USA, INC. | $144.95 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.55 | 2023-2025 | Jardiance |
| Getinge USA Sales, LLC | $122.56 | 2019-2021 | |
| Pfizer INC. | $101.46 | 2023-2025 | |
| Scpharmaceuticals INC. | $100.29 | 2024-2025 | |
| Medtronic, INC. | $89.72 | 2024 | Micra |
| Novo Nordisk INC | $69.10 | 2022-2025 | Wegovy |
| Abiomed | $50.74 | 2024 | Impella |
| W. L. Gore & Associates, INC. | $50.28 | 2020-2025 | Gore Viabahn Endoprosthesis |
| Convatec INC. | $37.87 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lsi Solutions INC | $35.77 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $30.56 | 2023 | Camzyos, Eliquis |
| Artivion, INC. | $26.23 | 2025 | Amds-Ascyrus Medical, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Lemaitre Vascular, INC. | $22.92 | 2025 | Xenosure Biologic Patch |
| Medtronic Vascular, INC. | $18.56 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.44 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.36 | 2023 | Lifevest |
| Sanara Medtech INC. | $16.77 | 2022 | |
| Terumo Medical Corporation | $15.10 | 2025 | Azur Cx Detachable, Glidesheath Slender |
| Merck Sharp & Dohme LLC | $13.39 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.